Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists

Autor:	Tzu-Yi Lin, Eugene Yu-Chuan Kang, Shih-Chieh Shao, Edward Chia-Cheng Lai, Sunir J. Garg, Kuan-Jen Chen, Je-Ho Kang, Wei-Chi Wu, Chi-Chun Lai, Yih-Shiou Hwang
Jazyk:	angličtina
Rok vydání:	2023
Předmět:	diabetic retinopathy glucagon-like peptide-1 receptor retrospective studies sodium-glucose transporter 2 inhibitors Diseases of the endocrine glands. Clinical endocrinology RC648-665
Zdroj:	Diabetes & Metabolism Journal, Vol 47, Iss 3, Pp 394-404 (2023)
Druh dokumentu:	article
ISSN:	2233-6079 2233-6087
DOI:	10.4093/dmj.2022.0221
Popis:	Background To compare risk of diabetic retinopathy (DR) between patients taking sodium-glucose cotransporter-2 inhibitors (SGLT2is) and those taking glucagon-like peptide-1 receptor agonists (GLP1-RAs) in routine care. Methods This retrospective cohort study emulating a target trial included patient data from the multi-institutional Chang Gung Research Database in Taiwan. Totally, 33,021 patients with type 2 diabetes mellitus using SGLT2is and GLP1-RAs between 2016 and 2019 were identified. 3,249 patients were excluded due to missing demographics, age
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/66e3066bad344a98864fe6b14776555b Zobrazit plný text záznamu View record in DOAJ Plný text ve formátu PDF